Skip to content

Paul Carter

Non-Executive Chairman

Paul has held a number of significant management and board roles in the life sciences sector spanning almost 25 years. In his most recent operational position, Paul was Executive Vice President, Chief Commercial Officer at Gilead Sciences where he oversaw unprecedented growth and commercial success in the US, Europe, Japan and other geographies. In his earlier role at Gilead, as Senior Vice President, Head of Commercial Operations International Markets, Paul built out Gilead affiliates in 38 countries over eight years as well as establishing alliances and partnerships with multinational companies and local distributors. Before this, he worked at GlaxoSmithKline where he was Regional Vice President of China and Hong Kong, leading over 3000 people across 31 offices. Over the past several years, Paul has held a variety of Board positions and is currently a Director at listed companies Hutchison China MediTech and Mallinkrodt Pharmaceuticals, and he was until recently a Director of Alder Biopharma (now acquired by Lundbeck for $1.95 billion). In addition, Paul also serves as a retained advisor and Board member for several private companies including Astorg Partners, Zambon Pharma, Indegene and Echosens. Paul is a fellow of the Chartered Institute of Management Accountants (FCMA), and holds a BA Honours degree in Business Studies from the University of West London in the U.K.